case_images: PMC10514904_01
case_images: Timeline of the patient's diagnosis, treatment, and evaluation of clinical efficacy. The patient achieved complete morphologic and genetic remission after induction therapy with idarubicin and cytarabine. During the subsequent consolidation therapy, the patient maintained a continuous complete remission, and the diagram illustrates in detail the therapeutic protocol for anti-infective treatment.
case_images: fonc-13-1237807-g001.jpg
case_images: PMC10514904_01_fonc-13-1237807-g001.jpg
case_images: f1
case_images: AE (cytarabine+etoposide), and VA (venetoclax+azacitidine). A treatment timeline is shown in  Figure 1 .
case_images: Imaging alterations during patient management. (A-C) The abdominal CT scan revealed diffuse small round low-density lesions in the spleen. (D-F) The splenic lesions exhibited significant resolution following treatment with amphotericin B. (G-I) Changes in contrast-enhanced ultrasound of the spleen during administration of amphotericin B therapy.
case_images: fonc-13-1237807-g002.jpg
case_images: PMC10514904_01_fonc-13-1237807-g002.jpg
case_images: f2
case_images: The imaging results of the patient throughout the course of treatment are shown in  Figure 2 .